|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02348 DAWNRAYS PHARMA
Nominal 
1.220 -0.020 (-1.613%) Non-current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Investment Properties | 2,739 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 1,115,805 | -6.335% | 1,191,266 | 1,032,131 | 657,396 | 489,777 |
| Land & other Lease Assets | 101,456 | -7.433% | 109,603 | 110,755 | 124,553 | 106,523 |
| Intangible Assets | 529,465 | -1.253% | 536,185 | 528,171 | 447,874 | 390,821 |
| Interests in Asso. & JCEs | 0 | -- | 25,345 | 87,250 | 98,669 | 77,440 |
| Other Non-current Assets | 152,998 | 130.944% | 66,249 | 70,215 | 26,529 | 6,643 |
| 1,902,463 | -1.358% | 1,928,648 | 1,828,522 | 1,355,021 | 1,071,204 | |
Current Assets
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Inventories | 211,107 | -12.674% | 241,746 | 203,476 | 246,028 | 180,759 | |
| Trade Receivables | 321,996 | -20.070% | 402,850 | 346,778 | 330,747 | 370,994 | |
| Cash & Bank Balances | 905,826 | 11.599% | 811,682 | 577,744 | 730,986 | 471,461 | |
| Other Current Assets | 281,267 | -1.358% | 285,139 | 288,775 | 240,953 | 691,969 | |
| Assets Held for Sale | 0 | -- | 2,578 | 94,263 | 0 | 0 | |
| 1,720,196 | -1.365% | 1,743,995 | 1,511,036 | 1,548,714 | 1,715,183 | ||
Current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||
| Trade Payables | 162,161 | -27.630% | 224,073 | 143,212 | 157,613 | 156,764 | ||
| S-T Debt & Leases | 120,424 | 1411.345% | 7,968 | 21,993 | 924 | 216,842 | ||
| Other Current Liabilities | 386,355 | -44.808% | 700,016 | 531,899 | 321,371 | 245,716 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 668,940 | -28.230% | 932,057 | 697,104 | 479,908 | 619,322 | |||
| Net Current Assets | 1,051,256 | 29.475% | 811,938 | 813,932 | 1,068,806 | 1,095,861 | ||
| Total Assets Less Current Liabilities | 2,953,719 | 7.777% | 2,740,586 | 2,642,454 | 2,423,827 | 2,167,065 | ||
Non-current Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||||
| L-T Debt & Leases | 103 | -76.802% | 444 | 1,527 | 2,025 | 2,841 | |||
| Other Non-current Liabilities | 94,382 | 4.549% | 90,275 | 243,066 | 238,210 | 137,912 | |||
| 94,485 | 4.151% | 90,719 | 244,593 | 240,235 | 140,753 | ||||
Capital and Reserves
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |||||
| Share Capital | 80,455 | 0.082% | 80,389 | 80,370 | 81,072 | 82,867 | ||||
| Reserves | 2,774,201 | 8.301% | 2,561,567 | 2,300,344 | 2,089,431 | 1,942,769 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 2,854,656 | 8.051% | 2,641,956 | 2,380,714 | 2,170,503 | 2,025,636 | ||||
| Non-controlling Interests | 4,578 | -42.131% | 7,911 | 17,147 | 13,089 | 676 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 2,859,234 | 7.901% | 2,649,867 | 2,397,861 | 2,183,592 | 2,026,312 | |||||
Commitments and Contingent Liabilities
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Commitments | 62,935 | -43.456% | 111,303 | 239,908 | 252,590 | 64,919 |
| Contingent Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 18/11/2024 13:12 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 493,046,000 |
| %Change | 92.640% |
| EPS / (LPS) | RMB 0.329 |
| NBV Per Share (¥) | RMB 2.178 |